Announcements Trials
Browse Landscape

Status

Completed 153Recruiting 69Active not recruiting 26Unknown 25Terminated 23Not yet recruiting 8Withdrawn 4Suspended 3Available 3Enrolling by invitation 2No longer available 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Expanded_access 3

Sponsor

Cancer Type

Genitourinary 6Sarcoma 3Gynecologic 3Gastrointestinal 3Thoracic 2Breast 2Lymphoid 1Dermatologic 1CNS 1

Conditions

Sarcoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Melanoma 2Glioblastoma 2Endometrial Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Primary Myelofibrosis 1Osteosarcoma 1Neurofibrosarcoma 1Neoplasms 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Hodgkin Disease 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Chordoma 1Chondrosarcoma 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1

Interventions

balstilimab 1Proton Pump Inhibitors 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Available × Prostatic Neoplasms × Gynecologic × Clear all
NCT06751524 2026-05-15

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Agenus Inc.

Available
DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Aveni Foundation

Available
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡